A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 128.46
GOOG 558.40
MSFT 43.85
FB 78.97
BAC 15.81

Recently Added

WNRL 29.83
TMUS 33.03
HART 3.67
CVA 21.67
TOT 53.63

Gaining Speed

ACIW 19.85
WNRL 29.83
QLYS 46.03
FDX 176.98
TMUS 33.03

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!